BMS-963272

N/A

Report date: 2025/02/10 20:00:43
NME

Base Information

Drug NameBMS-963272
Drug Alias NameBMS-963272
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase inhibitors
TargetsAlpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb Srlcompany
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A